Tag: Hannah L. Robbins
-
Nation & World
New vista for brain disorder research
For the first time, researchers describe the types of cells generated in brain organoids, networks of nerve cells, and show the greater diversity, complexity, and response to stimulation developed for nine months and longer.
-
Nation & World
Compound protects nerve cells targeted by diseases
Harvard researchers have identified a compound that helps protect the cells destroyed by spinal muscular atrophy, the most frequent fatal genetic disease of young children.
-
Nation & World
Progress in treating hearing loss
Harvard Stem Cell Institute researchers have developed a drug cocktail that unlocks the potential to regrow inner-ear hair cells, which could help combat hearing loss.
-
Nation & World
Medical hope on horizon
Stem cell science is accelerating development of therapies for diabetes, ALS, other diseases, researchers tell HUBweek sessions.
-
Nation & World
Progress against acute myeloid leukemia
A new drug compound developed by researchers at Massachusetts General Hospital and the Harvard Stem Cell Institute to treat acute myeloid leukemia is gentle enough to use with patients too frail to endure chemotherapy.
-
Nation & World
New weapon against breast cancer
Levels of a molecular marker in healthy breast tissue can predict a woman’s risk of getting cancer, according to new research from the Harvard Stem Cell Institute.
-
Nation & World
Brains or skin?
A protein that is necessary for the formation of the vertebrate brain has been identified by researchers at the Harvard Stem Cell Institute (HSCI) and Boston Children’s Hospital, in collaboration with scientists from Oxford and Rio de Janeiro.